Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials von Montefiori, David C., Karnasuta, Chitraporn, Huang, Ying, Ahmed, Hasan, Gilbert, Peter, de Souza, Mark S., McLinden, Robert, Tovanabutra, Sodsai, Laurence-Chenine, Agnes, Sanders-Buell, Eric, Moody, M. Anthony, Bonsignori, Mattia, Ochsenbauer, Christina, Kappes, John, Tang, Haili, Greene, Kelli, Gao, Hongmei, LaBranche, Celia C., Andrews, Charla, Polonis, Victoria R., Rerks-Ngarm, Supachai, Pitisuttithum, Punnee, Nitayaphan, Sorachai, Kaewkungwal, Jaranit, Self, Steve G., Berman, Phillip W., Francis, Donald, Sinangil, Faruk, Lee, Carter, Tartaglia, Jim, Robb, Merlin L., Haynes, Barton F., Michael, Nelson L., Kim, Jerome H.

Volltext

Virus Entry via the Alternative Coreceptors CCR3 and FPRL1 Differs by Human Immunodeficiency Virus Type 1 Subtype von NEDELLEC, R, COETZER, M, SHIMIZU, N, HOSHINO, H, POLONIS, V. R, MORRIS, L, MARTENSSON, U. E. A, BINLEY, J, OVERBAUGH, J, MOSIER, D. E

Volltext

In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegat... von MCCUTCHAN, F. E, HOELSCHER, M, HOFFMANN, O, RIEDNER, G, VON SONNENBURG, F, ROBB, M, BIRX, D. L, TOVANABUTRA, S, PIYASIRISILP, S, SANDERS-BUELL, E, RAMOS, G, JAGODZINSKI, L, POLONIS, V, MABOKO, L, MMBANDO, D

Volltext

Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades von Gorny, Miroslaw K, Williams, Constance, Volsky, Barbara, Revesz, Kathy, Cohen, Sandra, Polonis, Victoria R, Honnen, William J, Kayman, Samuel C, Krachmarov, Chavdar, Pinter, Abraham, Zolla-Pazner, Susan

Volltext

Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates von Gao, G, Peachman, KK, Wieczorek, L, Polonis, V, Alving, CR, Rao, M, Rao, VB

Volltext

P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay von Peachman, K, Wieczorek, L, Polonis, V R, Alving, C R, Rao, M

Volltext

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC von Chenine, A, Sanders-Buell, E, Wieczorek, L, Kim, J, Polonis, V, Tovanabutra, S

Volltext

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays von Brown, B K, Lombardi, K, Bryson, M, Currier, J, Thelian, D, Wieczorek, L, Kijak, G, Kappes, J C, Ochsenbauer-Jambor, C, Michael, N L, Montefiori, D, Polonis, V R

Volltext

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes von Matyas, GR, Wieczorek, L, Beck, Z, Ochsenbauer-Jambor, C, Kappes, JC, Michael, NL, Polonis, VR, Alving, CR

Volltext

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development von Polonis, V, Wieczorek, L, Kalyanaraman, V, Matyas, G, Whitney, S, Williams, C, Tovanabutra, S, Sanders-Buell, E, Wesberry, M, Ochsenbauer, C, Chenine, A, Rao, M, Tong, T, Alving, C, Cheng, H, Zolla-Pazner, S, Michael, N, VanCott, T, Marovich, M

Volltext

HIV-1 Vpr Activates Cell Cycle Inhibitor p21/Waf1/Cip1: A Potential Mechanism of G2/M Cell Cycle Arrest von Chowdhury, Iqbal H., Wang, Xiao-Fan, Landau, Nathaniel R., Robb, Merlin L., Polonis, Victoria R., Birx, Deborah L., Kim, Jerome H.

Volltext

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group von Scarlatti, G, Alcami, J, Bongertz, V, Fenyo, E, Heath, A, Heyndrickx, L, Holmes, H, Jansson, M, Lopalco, L, Malnati, M, Montefiori, D, Moog, C, Morris, L, Osmanov, S, Polonis, V, Ramaswamy, M, Sattentau, Q, Schuitemaker, H, Wrin, T

Volltext

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose von Sholukh, AM, Siddappa, NB, Shanmuganathan, V, Lakhashe, SK, Rasmussen, RA, Watkins, JD, Vyas, HK, Mukhtar, MM, Hemashettar, G, Thorat, S, Yoon, JK, Villinger, F, Novembre, FJ, Landucci, G, Forthal, DN, Ratcliffe, S, Robert-Guroff, M, Polonis, V, Montefiori, DC, Ertl, HC, Ruprecht, RM

Volltext

P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific von Wieczorek, L, Brown, B K, Wesberry, M, Ochsenbauer-Jambor, C, Kappes, J C, Lora, N, Gillis, A, Nzodom, C, Molnar, S, Michael, N L, Montefiori, D, Polonis, V R

Volltext

Induction of Primary Virus-Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Antibodies in Small Animals by Using an Alphavirus-Derived In Vivo Expression System von Dong, Ming, Zhang, Peng Fei, Grieder, Franziska, Lee, James, Krishnamurthy, Govindaraj, VanCott, Thomas, Broder, Christopher, Polonis, Victoria R, Yu, Xiao-Fang, Shao, Yiming, Faix, Dennis, Valente, Patricia, Quinnan, Jr, Gerald V

Volltext

International network for comparison of HIV neutralization assays : the NeutNet report von FENYO, E.M, HEATH, A, JASSOY, C, MALNATI, M, MONTEFIORI, D, MOOG, C, MORRIS, L, OSMANOV, S, POLONIS, V, SATTENTAU, Q, SCHUITEMAKER, H, SUTTHENT, R, DISPINSERI, S, WRIN, T, SCARLATTI, G, HOLMES, H, LUSSO, P, ZOLLA-PAZNER, S, DONNERS, H, HEYNDRICKX, L, ALCAMI, J, BONGERTZ, V

Volltext

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1 von VANCOTT, T. C, POLONIS, V. R, LOOMIS, L. D, MICHAEL, N. L, NARA, P. L, BIRX, D. L

Volltext

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes von MATYAS, Gary R, WIECZOREK, Lindsay, BECK, Zoltan, OCHSENBAUER-JAMBOR, Christina, KAPPES, John C, MICHAEL, Nelson L, POLONIS, Victoria R, ALVING, Carl R

Volltext

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β von Weaver, KL, Peachman, KK, Boonnak, K, Wieczorek, L, Matyas, GR, Asher, LM, Polonis, VR, Marovich, M, Alving, CR, Rao, M

Volltext

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination von Polonis, Victoria R, Brown, Bruce K, Borges, Andrew Rosa, Zolla-Pazner, Susan, Dimitrov, Dimiter S, Zhang, Mei-Yun, Barnett, Susan W, Ruprecht, Ruth M, Scarlatti, Gabriella, Fenyö, Eva-Maria, Montefiori, David C, McCutchan, Francine E, Michael, Nelson L

Volltext